TAMOXIFEN THERAPY IN PRIMARY BREAST-CANCER - BIOLOGY, EFFICACY, AND SIDE-EFFECTS

被引：163

作者：

LOVE, RR

机构：

[1] UNIV WISCONSIN,CTR CLIN CANC,DEPT HUMAN ONCOL,MADISON,WI 53706

[2] UNIV WISCONSIN,CTR CLIN CANC,CANC PREVENT PROGRAM,MADISON,WI 53706

[3] UNIV WISCONSIN,CTR CLIN CANC,BREAST PROGRAM,MADISON,WI 53706

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1989年 / 7卷 / 06期

关键词：

D O I：

10.1200/JCO.1989.7.6.803

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：803 / 815

页数：13

共 50 条

[31] OVERPROLONGED ADJUVANT TAMOXIFEN THERAPY IN BREAST-CANCER
STOLL, BA
[J]. ANNALS OF ONCOLOGY, 1991, 2 (06) : 401 - 403
[32] TAMOXIFEN (ANTIESTROGEN) THERAPY IN ADVANCED BREAST-CANCER
KIANG, DT
KENNEDY, BJ
[J]. ANNALS OF INTERNAL MEDICINE, 1977, 87 (06) : 687 - 690
[33] TAMOXIFEN AS ADJUVANT THERAPY IN BREAST-CANCER PATIENTS
NICOLINI, A
TOSCANO, S
GIULIANI, L
DIMARCO, G
CARPI, A
[J]. ANTICANCER RESEARCH, 1986, 6 (03) : 397 - 397
[34] TAMOXIFEN THERAPY IN BREAST-CANCER CONTROL WORLDWIDE
LOVE, RR
KOROLTCHOUK, V
[J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1993, 71 (06) : 795 - 803
[35] PRIMARY ENDOCRINE THERAPY FOR ADVANCED BREAST-CANCER - TO START WITH TAMOXIFEN OR WITH MEDROXYPROGESTERONE ACETATE
CASTIGLIONEGERTSCH, M
PAMPALLONA, S
VARINI, M
CAVALLI, F
BRUNNER, K
SENN, HJ
GOLDHIRSCH, A
METZGER, U
[J]. ANNALS OF ONCOLOGY, 1993, 4 (09) : 735 - 740
[36] SIDE-EFFECTS OF LEVAMISOLE IN ADJUVANT CHEMO-IMMUNOTHERAPY OF OPERABLE BREAST-CANCER
GUNDERSEN, S
FOSSA, SD
[J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 1980, 7 (04) : 271 - 272
[37] Does Tamoxifen reduce Side-Effects of PCa-Therapy?
不详
[J]. AKTUELLE UROLOGIE, 2012, 43 (06) : 375 - 375
[38] PREOPERATIVE CHEMOTHERAPY - A MODEL FOR STUDYING THE BIOLOGY AND THERAPY OF PRIMARY BREAST-CANCER
MAMOUNAS, EP
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) : 537 - 540
[39] THERAPY OF PRIMARY BREAST-CANCER
HOLLAND, JF
[J]. ISRAEL JOURNAL OF MEDICAL SCIENCES, 1977, 13 (08): : 829 - 836
[40] TAMOXIFEN AND BREAST-CANCER
ESTEVE, MP
[J]. MEDICINA CLINICA, 1991, 96 (17): : 657 - 658

← 1 2 3 4 5 →